Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001385671 | SCV001585615 | pathogenic | not provided | 2020-03-17 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Arg1009Glyfs*21) in the LAMB3 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs777292177, ExAC 0.03%). This variant has been observed in individual(s) with epidermolysis bullosa (PMID: 11023379). ClinVar contains an entry for this variant (Variation ID: 370321). Loss-of-function variants in LAMB3 are known to be pathogenic (PMID: 11023379, 16473856). |
Counsyl | RCV000410326 | SCV000485592 | likely pathogenic | Junctional epidermolysis bullosa gravis of Herlitz | 2016-01-15 | no assertion criteria provided | clinical testing | This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. |